The Question
A 38-year-old woman with a 10-year history of generalized tonic-clonic epilepsy, well-controlled on levetiracetam 1000 mg twice daily, presents for follow-up. She reports two breakthrough tonic-clonic seizures in the past three months, prior to which she had been seizure-free for over five years. She affirms medication adherence, and a levetiracetam level drawn one month ago was in the therapeutic range. Her medical history is also significant for migraine headaches without aura, for which she takes ibuprofen as needed. Her neurologic examination is non-focal. Vitals are stable. She expresses frustration with the seizures and their impact on her life. Which of the following is the most appropriate next step in management?
See the answer and explanation below:
Post-Call Recovery Reads
Finished your notes? Time to swap the pager for a crown. Kingdoms of Silent Sorrows is the ultimate 'brain-break', a high-stakes fantasy featuring a Fae princess, a Vampire king, and an enemies-to-lovers arc that will actually make you forget about your rounding list. No p-values, just fated mates and forbidden magic.
View on AmazonThe Correct Answer
D
Explanation
High-Yield Pearl: In patients with co-morbid epilepsy and migraine headaches, selecting an antiepileptic drug that treats both conditions, such as topiramate or valproate, is an optimal management strategy.
Detailed Reasoning: The most appropriate step is to add topiramate. This patient with established generalized epilepsy is having breakthrough seizures despite adherence to levetiracetam with a therapeutic level. While increasing the current medication dose is a valid option, this patient also has a history of migraines. Topiramate is a broad-spectrum antiepileptic agent that is also established as an effective prophylactic therapy for migraines. Therefore, adding topiramate represents a rational choice that can address both of her neurological conditions. Increasing the levetiracetam dose is a reasonable alternative but does not offer any benefit for her migraines. Switching to valproic acid, while effective for both seizures and migraines, is generally avoided in women of childbearing potential due to its significant teratogenic risk and other side effects (e.g., weight gain, hair loss). Adding lamotrigine is a reasonable option for seizure control but has no proven benefit for migraine prophylaxis. An ambulatory EEG is not the next best step as her seizure type is already known and the immediate issue is inadequate seizure control on her current regimen.
See you tomorrow morning!